187 related articles for article (PubMed ID: 35491102)
1. A method for the generation of pseudovirus particles bearing SARS coronavirus spike protein in high yields.
Fujioka Y; Kashiwagi S; Yoshida A; Satoh AO; Fujioka M; Amano M; Yamauchi Y; Ohba Y
Cell Struct Funct; 2022 Jun; 47(1):43-53. PubMed ID: 35491102
[TBL] [Abstract][Full Text] [Related]
2. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.
Fukushi S; Watanabe R; Taguchi F
Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867
[TBL] [Abstract][Full Text] [Related]
3. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
4. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
[TBL] [Abstract][Full Text] [Related]
5. Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.
Xiong HL; Wu YT; Cao JL; Yang R; Liu YX; Ma J; Qiao XY; Yao XY; Zhang BH; Zhang YL; Hou WH; Shi Y; Xu JJ; Zhang L; Wang SJ; Fu BR; Yang T; Ge SX; Zhang J; Yuan Q; Huang BY; Li ZY; Zhang TY; Xia NS
Emerg Microbes Infect; 2020 Dec; 9(1):2105-2113. PubMed ID: 32893735
[TBL] [Abstract][Full Text] [Related]
6. Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019.
Salazar-García M; Acosta-Contreras S; Rodríguez-Martínez G; Cruz-Rangel A; Flores-Alanis A; Patiño-López G; Luna-Pineda VM
Front Microbiol; 2021; 12():817200. PubMed ID: 35095820
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.
Havranek KE; Jimenez AR; Acciani MD; Lay Mendoza MF; Reyes Ballista JM; Diaz DA; Brindley MA
Viruses; 2020 Dec; 12(12):. PubMed ID: 33353101
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation.
Chen HY; Huang C; Tian L; Huang X; Zhang C; Llewellyn GN; Rogers GL; Andresen K; O'Gorman MRG; Chen YW; Cannon PM
J Virol; 2021 Oct; 95(22):e0096621. PubMed ID: 34495700
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.
Nie J; Li Q; Wu J; Zhao C; Hao H; Liu H; Zhang L; Nie L; Qin H; Wang M; Lu Q; Li X; Sun Q; Liu J; Fan C; Huang W; Xu M; Wang Y
Emerg Microbes Infect; 2020 Dec; 9(1):680-686. PubMed ID: 32207377
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay.
Almahboub SA; Algaissi A; Alfaleh MA; ElAssouli MZ; Hashem AM
Front Microbiol; 2020; 11():2020. PubMed ID: 33013745
[TBL] [Abstract][Full Text] [Related]
11. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
12. Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector.
Liang Z; Wu X; Wu J; Liu S; Tong J; Li T; Yu Y; Zhang L; Zhao C; Lu Q; Qin H; Nie J; Huang W; Wang Y
Emerg Microbes Infect; 2023 Dec; 12(2):e2261566. PubMed ID: 37727107
[No Abstract] [Full Text] [Related]
13. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization.
Shan D; Tang X; Liu R; Pan D; Wang X; Ge J; Wen Z; Bu Z
Virol Sin; 2022 Apr; 37(2):248-255. PubMed ID: 35234625
[TBL] [Abstract][Full Text] [Related]
15. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
Kapadia SU; Simon ID; Rose JK
Virology; 2008 Jun; 376(1):165-72. PubMed ID: 18396306
[TBL] [Abstract][Full Text] [Related]
16. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.
Carpinteiro A; Gripp B; Hoffmann M; Pöhlmann S; Hoertel N; Edwards MJ; Kamler M; Kornhuber J; Becker KA; Gulbins E
J Biol Chem; 2021; 296():100701. PubMed ID: 33895135
[TBL] [Abstract][Full Text] [Related]
18. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
[TBL] [Abstract][Full Text] [Related]
19. Synergistic surface-enhanced Raman scattering effect to distinguish live SARS-CoV-2 S pseudovirus.
Sitjar J; Xu HZ; Liu CY; Wang JR; Liao JD; Tsai HP; Lee H; Liu BH; Chang CW
Anal Chim Acta; 2022 Feb; 1193():339406. PubMed ID: 35058004
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
